Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Estrogen replacement therapy may improve quality-of-life in postmenopausal women
with endometrial cancer. It is not yet known whether estrogen replacement therapy will affect
cancer recurrence.
PURPOSE: Randomized double-blinded phase III trial to determine the effectiveness of estrogen
replacement therapy in treating women who have stage I or stage II endometrial cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Gynecologic Oncology Group
Collaborators:
Eastern Cooperative Oncology Group National Cancer Institute (NCI) Southwest Oncology Group